Management of Insect Bite Allergic Reactions

Immediate Treatment of Systemic Reactions

Administer intramuscular epinephrine immediately as first‑line therapy for anaphylaxis: 0.3–0.5 mg in adults, 0.01 mg/kg (max 0.3 mg) in children, injected into the anterolateral thigh【1】【2】.
Intramuscular injection in the thigh achieves faster and higher plasma epinephrine concentrations than sub‑cutaneous or arm injection【1】【2】 (moderate‑quality evidence).
Repeat epinephrine dosing may be required for persistent or recurrent symptoms【1】【2】 (moderate‑quality evidence).
No absolute contraindication to epinephrine exists even in patients with hypertension, cardiac arrhythmias, or β‑blocker therapy; the risk of untreated anaphylaxis outweighs potential cardiac effects【1】【2】 (high‑quality evidence).

Post‑Acute Care for Systemic Reactions

Prescribe an epinephrine autoinjector for lifelong carry‑by use【1】【2】 (high‑quality evidence).
Provide structured training on proper autoinjector technique and indications for self‑administration【1】【2】 (moderate‑quality evidence).
Refer the patient to an allergist‑immunologist for venom‑specific IgE testing (skin or in‑vitro) and evaluation for venom immunotherapy (VIT)【1】【2】 (high‑quality evidence).
Deliver education on insect‑avoidance measures (see “Insect Avoidance Strategies”)【1】【2】.
Recommend a medical identification bracelet or necklace indicating allergy to insect stings【1】【2】.

Venom Immunotherapy (VIT)

VIT reduces the risk of subsequent systemic reactions to < 5 %, and any reactions that occur during therapy are generally milder than pre‑treatment reactions【3】 (high‑quality evidence).
Indications:
- Adults with any systemic reaction beyond isolated cutaneous signs.
- Children with systemic reactions involving respiratory or cardiovascular symptoms【3】 (high‑quality evidence).
VIT may be considered for adults who have only cutaneous systemic manifestations, although this remains somewhat controversial【3】 (moderate‑quality evidence).
If skin testing is negative after a convincing anaphylactic episode, perform in‑vitro IgE testing or repeat skin testing after ≈ 6 weeks, as tests can be temporarily non‑reactive【3】 (moderate‑quality evidence).
Recommended duration is 3–5 years; 80–90 % of patients remain free of systemic reactions after discontinuation【3】【4】 (high‑quality evidence).
Extended or indefinite VIT is advised for individuals with a history of severe anaphylaxis featuring shock or loss of consciousness【3】【4】 (moderate‑quality evidence).

Insect Avoidance Strategies

Have nests of stinging insects removed by trained professionals from the home environment【1】【2】.
Avoid brightly colored clothing, flowery prints, and strongly scented materials that attract insects【1】【2】.
Wear long pants, long‑sleeved shirts, socks, closed shoes, and work gloves when outdoors【1】【2】.
Refrain from walking barefoot or in open footwear such as sandals【1】【2】.
Exercise caution near bushes, eaves, attics, garbage containers, and picnic areas【1】【2】.
Keep insecticides readily available for killing stinging insects from a distance (note: repellents are ineffective against stinging insects)【1】【2】.
Avoid eating or drinking outdoors and use caution with opaque containers and straws【1】【2】.

Medication Interactions

β‑adrenergic blocking agents increase the risk of severe anaphylaxis to stings and to VIT; discontinue them when feasible【4】 (moderate‑quality evidence).
Angiotensin‑converting enzyme (ACE) inhibitors are associated with a higher risk of severe anaphylaxis (odds ratio ≈ 2.27); consider alternative antihypertensives when appropriate【4】 (moderate‑quality evidence).
If these medications cannot be stopped, VIT decisions should be individualized, but for patients with life‑threatening sting reactions, the benefit of VIT generally outweighs medication‑related risk【4】.

Diagnostic Considerations

Large local swelling should not be mistaken for infection; antibiotics are indicated only when a secondary bacterial infection is clearly present【5】 (low‑quality evidence).
Among patients with positive venom‑specific IgE, 30–60 % will experience a systemic reaction if re‑stung, not 100 %【3】 (moderate‑quality evidence).
Anaphylaxis can rarely (< 1 %) occur despite negative skin and in‑vitro tests; such cases may be associated with underlying systemic mastocytosis【3】 (low‑quality evidence).

Management of Simple and Large Local Reactions

Simple local reactions (redness, swelling, itching, pain) typically resolve within 24 hours and require minimal intervention【5】.
Apply cold compresses to reduce pain and swelling in simple local reactions【5】 (moderate‑quality evidence).
Oral antihistamines (e.g., cetirizine) alleviate itching and discomfort in simple local reactions【5】 (moderate‑quality evidence).
Oral analgesics such as acetaminophen or ibuprofen may be used for pain relief in simple local reactions【5】 (moderate‑quality evidence).
Do not prescribe antibiotics for simple local reactions unless a clear secondary bacterial infection is evident【5】 (low‑quality evidence).
Large local reactions (> 10 cm, lasting 5–10 days) may be treated with oral corticosteroids initiated within the first 24–48 hours for severe cases, although definitive controlled‑trial evidence is lacking【5】 (low‑quality evidence).
Continue cold compresses and oral antihistamines for large local reactions【5】.
Up to 10 % of patients with large local reactions may later develop systemic reactions; prescribing an epinephrine autoinjector is reasonable in this group【5】.
Venom‑specific IgE testing and VIT are generally not indicated for large local reactions unless the patient has frequent unavoidable exposure and demonstrable venom‑specific IgE【5】.

Insect Bite Reaction Management

Immediate Treatment Approaches

The American Academy of Allergy, Asthma, and Immunology recommends administering oral antihistamines, such as cetirizine, for local reactions, due to minimal sedation 6, 7
For systemic reactions, the American College of Allergy, Asthma, and Immunology advises immediate intramuscular epinephrine (0.01 mg/kg up to 0.3 mg in children, 0.3-0.5 mg in adults) in the anterolateral thigh 6, 8
The American Heart Association suggests that delayed epinephrine use is associated with fatal outcomes, emphasizing the importance of prompt administration 6, 8
For large local reactions, cold compresses and oral antihistamines are recommended for pain and swelling reduction, and oral corticosteroids may be considered for severe cases 9, 10, 11

Post-Acute Management and Prevention

The American Academy of Allergy, Asthma, and Immunology recommends that all patients who experience systemic reactions receive a prescription for an epinephrine autoinjector and carry it at all times 6, 11, 12
Patients with systemic reactions should be referred to an allergist-immunologist for venom-specific IgE testing and consideration of venom immunotherapy (VIT) 6, 8
VIT is indicated for adults with any systemic reaction beyond isolated cutaneous manifestations, and patients with severe anaphylaxis history may require extended or indefinite duration 11, 12
The American College of Allergy, Asthma, and Immunology suggests that VIT reduces the risk of subsequent systemic reactions to less than 5% and is highly effective 12

Special Considerations

The American Heart Association states that there is no contraindication to epinephrine use in life-threatening anaphylaxis, even in patients with hypertension, cardiac arrhythmias, or those taking β-blockers 11, 12
The American Academy of Ophthalmology recommends that any sting to the eye itself requires immediate medical evaluation due to the risk of permanent vision loss 8

Venom Immunotherapy (VIT) Guidelines

Indications for Venom Immunotherapy

VIT is recommended for adults who have experienced any systemic reaction beyond isolated skin signs and for children who have systemic reactions involving respiratory or cardiovascular symptoms. 13

Diagnostic Evaluation Prior to VIT

Patients with systemic reactions should be referred to an allergist‑immunologist for venom‑specific IgE testing, with skin testing preferred as the initial modality. 13, 14
Because patients often misidentify the offending insect, allergy testing combined with a detailed history is essential for accurate species identification. 13, 14, 15

Efficacy of Venom Immunotherapy

VIT has been shown to prevent death from subsequent stings in individuals with hypersensitivity to insect venom. 13, 14, 15

Maintenance Dosing Schedule

After the initial build‑up phase, the maintenance dose interval can be extended to every 4 weeks during the first year, and later to every 6–12 weeks for long‑term therapy. 14, 16

Management of Honey‑Bee Sting Reactions

Simple Local Reactions

Most honey‑bee stings cause only localized redness, swelling, itching and pain that resolve within 24 hours in the general population. [17][18]19
Applying a cold compress to the sting site reduces pain and swelling. 20

Large Local Reactions

Large local reactions are defined as swelling > 10 cm in diameter, which enlarges for 24–48 h and resolves over 5–10 days. [17][18]19
A short course of oral corticosteroids (e.g., prednisolone ≈ 50 mg daily for 3 days in adults) started within the first 24–48 h can lessen severity in selected cases. [21][20]
Antibiotics are indicated only when a clear secondary bacterial infection develops. [21][20]

Systemic Anaphylactic Reactions

Systemic reactions may present with urticaria, angio‑edema, bronchospasm, upper‑airway obstruction, hypotension/shock, gastrointestinal or neurologic symptoms that are not contiguous with the sting site. [17][18]19
Immediate intramuscular epinephrine is first‑line therapy (0.3–0.5 mg for adults; 0.01 mg/kg, max 0.3 mg for children). [21][22]
Re‑dosing of epinephrine may be required for persistent or recurrent symptoms. [18][19]
No contraindication exists for epinephrine use in life‑threatening anaphylaxis, even in patients with hypertension, cardiac arrhythmias, or β‑blocker therapy. [18][19]22
Delayed epinephrine administration is associated with fatal outcomes; antihistamines and corticosteroids are not substitutes. [21][20]
Supportive measures and rapid transport to an emergency department are recommended. [21][20]

Post‑Acute Management

Epinephrine Auto‑Injector Prescription

All individuals who experience a systemic reaction should be prescribed an epinephrine auto‑injector (300 µg for adults; 150 µg for children ≈ 15–30 kg). [17][18]19
Consider prescribing more than one auto‑injector because some patients may need multiple doses. [17][18]
Structured training on proper technique and indications for self‑administration should be provided. [18][19]
Patients should carry the auto‑injector at all times. [17][18]19

Allergy Referral and Testing

Refer all patients with systemic reactions to an allergist‑immunologist for venom‑specific IgE testing (skin testing preferred) and evaluation for venom immunotherapy (VIT). [21][22]
If skin testing is negative after a severe reaction, perform in‑vitro IgE testing or repeat skin testing ≥ 6 weeks after the sting. 21
Baseline serum tryptase measurement is advisable because 3–5 % of severe‑reaction patients have underlying mastocytosis. 23

Venom Immunotherapy (VIT)

VIT is recommended for adults with any systemic reaction beyond isolated cutaneous signs and for children with respiratory or cardiovascular systemic symptoms. 21
VIT reduces the risk of subsequent systemic reactions to < 5 % compared with 25–70 % without treatment. 20
A treatment duration of 3–5 years is advised; 80–90 % of patients remain free of systemic reactions after discontinuation. 21
Extended or indefinite VIT is indicated for patients with a history of severe anaphylaxis involving shock or loss of consciousness. 21
VIT may be considered for adults with only cutaneous systemic manifestations, though this remains somewhat controversial. 21

Insect‑Avoidance Education

Have bee nests removed by trained professionals from the home environment. 22
Advise avoidance of brightly colored clothing, flowery prints and strongly scented products. 22
Recommend wearing long pants, long‑sleeved shirts, socks, closed shoes and work gloves when outdoors. 22
Counsel patients not to walk barefoot or in open footwear. 22
Encourage caution near bushes, eaves, attics, garbage containers and picnic areas. 22
Keep insecticides available for killing stinging insects from a safe distance. 22
Suggest wearing a medical‑identification bracelet or necklace indicating a bee‑sting allergy. [21][22]

Medication Considerations

Angiotensin‑converting‑enzyme (ACE) inhibitors are associated with a higher risk of severe anaphylaxis (odds ratio ≈ 2.27); consider alternative antihypertensive agents when appropriate. 23

Critical Pitfalls to Avoid

Antihistamines or corticosteroids must not be used as substitutes for epinephrine in anaphylaxis. [21][20]
Epinephrine should never be withheld in patients on β‑blockers or with cardiac disease during anaphylaxis; the risk of untreated anaphylaxis outweighs potential cardiac risks. [18][19]22